EP4429693
MONOMERIC ANNEXIN A5 FOR USE IN THE TREATMENT OF MACULAR OEDEMA OR RETINAL VEIN OCCLUSION
:
EP einkaleyfi: Þýðing ekki lögð inn:
18.5.2023:
26.2.2025:
23730718.6
:
17.5.2043
:
MONOMERIC ANNEXIN A5 FOR USE IN THE TREATMENT OF MACULAR OEDEMA OR RETINAL VEIN OCCLUSION
18.5.2023
26.2.2025
:
Annexin Pharmaceuticals AB:
Kammakargatan 48, 111 60 Stockholm, SE
:
FROSTEGÅRD, Anna:
11160 Stockholm, SE
:
HAEGERSTRAND, Anders:
11160 Stockholm, SE
:
202207263:
18.5.2022:
GB
:
EP2023063441:
18.5.2023
:
A61K 38/17, A61P 27/02